- THIS ARTICLE
- Full Text (Rapid PDF)
-
All Versions of this Article:
genetics.106.067298v1
175/3/1451 most recent - Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Rubio-Aliaga, I.
-
Articles by Hrab
de Angelis, M.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Rubio-Aliaga, I.
-
Articles by Hrab
de Angelis, M.
doi:10.1534/genetics.106.067298
A more recent version of this article appeared on March 1, 2007.
REGULAR RESEARCH PAPERS |
A genetic screen for modifiers of Delta1 dependent Notch signaling function in the mouse
Isabel Rubio-Aliaga 1, Dian Soewarto 1, Sibylle Wagner 1, Matthias Klaften 1, Helmut Fuchs 1, Svetoslav Kalaydjiev 2, Dirk H. Busch 2, Martina Klempt 3, Birgit Rathkolb 3, Eckhard Wolf 3, Koichiro Abe 1, Stefan Zeiser 1, Gerhard K. H. Przemeck 1, Johannes Beckers 1 and Martin Hrab
de Angelis 1*
de Angelis 1*
1 GSF Research Center for Environment and Health
2 Technical University Munich
3 University of Munich
* To whom correspondence should be addressed. E-mail: hrabe{at}gsf.de.
Submitted on October 25, 2006
Revised on November 20, 2006
Accepted on 11 December 2006
The Notch signaling pathway is an evolutionary conserved transduction pathway involved in embryonic patterning and regulation of cell fates during development. Recent studies have demonstrated that this pathway is integral to a complex system of interactions, which are also involved in distinct human diseases. Delta1 is one of the known ligands of the Notch receptors. Mice homozygous for a loss-of-function allele of the Delta1 gene, Dll1lacZ/lacZ, die during embryonic development. Here, we present the results of two phenotype-driven modifier screens. Heterozygous Dll1lacZ knockout animals were crossed with ENU mutagenized mice and screened for dysmorphological, clinical chemical and immunological variants that are dependent on the Delta1 loss-of-function allele. First, we show that mutagenized heterozygous Dll1lacZ offspring have reduced body weight and altered specific clinical chemical parameters including changes in metabolites and electrolytes relevant for kidney function. In our mutagenesis screen we have successfully generated 35 new mutant lines. Of major interest are seven mutant lines that exhibit a Dll1lacZ/+-dependent phenotype. These mutant mouse lines provide excellent in vivo tools to study the role of Notch signaling in kidney and liver function, cholesterol and iron metabolism, in cell-fate decisions and during maturation of T cells in the immune system.
Key Words: Delta1, Notch signaling pathway, Notch1, genetic screen, modifier